Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic disorders. Now, a clinical trial reports that a single dose can ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies are working hard to make advancements that can help patients. Stem cells ...

On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the ...

Zemcelpro(R) (dorocubicel) achieved remarkable and clinically meaningful survival results in patients with high- and very high-risk acute leukemias and myelodysplastic syndromes -- Topline results ...

Neurodegenerative diseases like Parkinson's and Alzheimer's are characterized by irreversible neuron damage and limited natural repair mechanisms. While stem cell therapy holds great promise for ...

CAMBRIDGE, England--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures and a pioneer in synthetic biology, today announces the successful defence of its foundational European ...

Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial ...

NeuroScientific Biopharmaceuticals has begun transferring the production of stem cells for its StemSmart therapy to Q-Gen in Brisbane, ahead of Crohn’s disease clinical trials.

Share on Pinterest An experimental stem cell therapy could help reverse corneal damage in people with a vision-threatening eye condition. Image credit: daliloveart/Getty Images. Researchers estimate ...

From silver nanofibers to smart, sensory-packed dressings, the next generation of wound-healing technology is blurring the line between biology and engineering. A new review has looked at what’s ...